New patent for Foldrx Pharms drug VYNDAMAX

   November 14, 2023    Comments Off on New patent for Foldrx Pharms drug VYNDAMAX    Posted in: Patent Added

Annual Drug Patent Expirations for VYNDAMAX Vyndamax is a drug marketed by Foldrx Pharms and is included in one NDA. It is available from one supplier. There are three patents…

The post New patent for Foldrx Pharms drug VYNDAMAX appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog